Ceribell CBLL
NASDAQ CBLL
$24.31 -0.58 (-2.33%)
As of: Aug 20, 2026 · 3:59 PM EDT

Ceribell (CBLL) Liabilities and Shareholders Equity (2023 - 2026)

Ceribell's (CBLL) quarterly Liabilities and Shareholders Equity came in at $178.1 million in Q1 2026, down 16.58% YoY from $213.5 million in Q1 2025, and down 9.05% on a QoQ basis from $195.8 million in Q4 2025.

Ceribell (CBLL) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends

Ceribell (CBLL) has 4 years of Liabilities and Shareholders Equity data on file, last reported at $178.1 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 16.58% year-over-year to $178.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $781.1 million (up 60.74% YoY) and the FY2025 annual result came in at $195.8 million, down 13.14% from the prior year.
  • Liabilities and Shareholders Equity fell to $178.1 million in Q1 2026, from $195.8 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $225.4 million in Q4 2024 to a low of $47.1 million in Q3 2024.
  • A 4-year average of $165.7 million and a median of $197.7 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2025 — Liabilities and Shareholders Equity soared 323.99% — and 2026, when it decreased 16.58%.
  • Tracing CBLL's Liabilities and Shareholders Equity over 4 years: stood at $58.9 million in 2023, then soared by 282.56% to $225.4 million in 2024, then decreased by 13.14% to $195.8 million in 2025, then dropped by 9.05% to $178.1 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $178.1 million (Q1 2026), $195.8 million (Q4 2025), and $199.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 109.22 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 31.04 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 10.74 Bn
10 Ceribell 923.42 Mn 794.16 Mn 25.94 Mn 166.35 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 166.35 Mn
Mar 31, 2026 178.08 Mn
Dec 31, 2025 195.80 Mn
Sep 30, 2025 199.53 Mn
Jun 30, 2025 207.69 Mn
Mar 31, 2025 213.47 Mn
Dec 31, 2024 225.41 Mn
Sep 30, 2024 47.06 Mn
Dec 31, 2023 58.92 Mn